Clinical trial
Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients
NCT00252655 · Wayne State University, Other · Unknown status
Key facts
| NCT number | NCT00252655 |
|---|---|
| Title | Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients |
| Official title | Use of Sirolimus Vs. Tacrolimus As The Primary Agent In Immunosuppressive Regimen For African-American Renal Allograft Recipients With Immediate Graft Function: A Pilot Study |
| Lead sponsor | Wayne State University, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | Rapamune and Prograf |
| Enrollment | 40 |
| Start date | Jan 1, 2004 |
| Completion | Jun 1, 2009 |
| First posted | Nov 11, 2005 |
| Last update posted | Apr 19, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: